Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.72 |
| ▸ | TSG101 | Q99816 | 19/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29321848 | 0.94 | ALB (0.82) | ALBTSG101 | |
| SCHEMBL29438543 | 0.50 | FTO (0.45) | — | |
| SCHEMBL1650598 | 0.50 | FTO (0.45) | — | |
| Segetalin C SCHEMBL149059 | 0.49 | HDAC4 (0.48) | — | |
| Hydrochloric Acid SCHEMBL2264011 | 0.48 | JAK2 (0.57) | — | |
| SCHEMBL16602999 | 0.48 | NAALAD2 (0.60) | — | |
| SCHEMBL20073866 | 0.48 | ALB (0.45) | ALB | |
| SCHEMBL9754027 | 0.48 | HDAC1 (0.84) | — | |
| Segetalin D SCHEMBL151348 | 0.47 | HDAC4 (0.54) | — | |
| SCHEMBL26528944 | 0.47 | NQO1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238458-A1 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238458-A1 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | FAP, FIBP, FGFR1 | ALB 174/4885TSG101 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.